Riskpilot← Back to searchSign inGet full accessMEDICOLINK CONSULTANCY ApS
APSActiveCVR 32263054Kildebakken 2Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20091 employeeswww.medicolink.com
Revenue 2024
DKK -169K
-89% vs 2023
EBITDA margin
312.2%
+74% vs 2023
Equity ratio
0.6%
Financial strength
Net profit 2024
DKK 582K
+139% vs 2023
| Revenue | DKK -169K | -89% |
| EBITDA | DKK -528K | +74% |
| Net profit | DKK 582K | +139% |
| Total assets | DKK 22,3M | -29% |
| Equity | DKK 135K | +131% |
| Employees | 1 | — |
Legal name
MEDICOLINK CONSULTANCY ApS
CVR number
32263054
Legal form
Anpartsselskab
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
11. juni 2009
Share capital
DKK 156.250
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive konsulentvirksomhed med rekruttering og opkvalificering som speciale og dermed beslægtet virksomhed.
Address
Kildebakken 2
Phone
+4526141020
Website
www.medicolink.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.367 | 3.181 | 1.299 | 725 | 580 | -428 | -700 | -991 | 107 | -1.273 | -1.715 | -1.521 | -169 |
| Staff expenses | -1.335 | -1.846 | -1.259 | -1.148 | -1.349 | -1.346 | -1.173 | -526 | -380 | -405 | -379 | -424 | -359 |
| EBITDA | 1.032 | 1.335 | 40 | -493 | -776 | -1.774 | -1.873 | -1.517 | -272 | -1.678 | -2.094 | -2.051 | -528 |
| Depreciation & amort. | -24 | -16 | -5 | -0 | -0 | -0 | -0 | -0 | -2 | -2 | -2 | -0 | -0 |
| EBIT | 1.007 | 1.319 | 35 | -493 | -776 | -1.774 | -1.873 | -1.517 | -275 | -1.681 | -2.097 | -2.051 | -528 |
| Net financials | 124 | 260 | 1.361 | 2.627 | 844 | -567 | -525 | 3.041 | 1.127 | -595 | -455 | 560 | 1.109 |
| Profit before tax | 1.132 | 1.579 | 1.396 | 2.134 | 68 | -2.341 | -2.398 | 1.524 | 853 | -2.276 | -2.552 | -1.490 | 582 |
| Tax | 299 | 472 | 123 | 7 | -174 | -519 | 496 | -9 | -41 | -52 | -41 | -0 | -0 |
| Net profit | 832 | 1.107 | 1.273 | 2.127 | 242 | -1.823 | -2.894 | 1.533 | 893 | -2.224 | -2.511 | -1.490 | 582 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.230 | 13.040 | 15.873 | 21.340 | 23.936 | 31.416 | 32.128 | 32.849 | 30.477 | 31.823 | 31.488 | 31.232 | 22.266 |
| Equity | 3.647 | 4.754 | 6.026 | 7.954 | 7.995 | 6.072 | 3.207 | 4.810 | 5.703 | 3.480 | 1.042 | -433 | 135 |
| Long-term debt | 46 | 2.758 | 4.555 | 8.507 | 10.596 | 15.208 | 18.015 | 18.230 | 17.013 | 19.027 | 19.776 | 19.133 | 15.217 |
| Short-term debt | 5.256 | 5.226 | 5.119 | 4.725 | 5.345 | 10.135 | 10.906 | 9.809 | 7.760 | 9.316 | 10.670 | 12.532 | 6.914 |
| Total debt | 5.302 | 7.983 | 9.674 | 13.232 | 15.941 | 25.343 | 28.921 | 28.039 | 24.774 | 28.343 | 30.446 | 31.665 | 22.131 |
EBITDA margin
-52765100.0%
This company
15.8%
Market median
-333956429% vs market
20122024
Equity ratio
0.6%
This company
38.2%
Market median
-98% vs market
20122024
Return on equity
429.5%
This company
18.4%
Market median
+2234% vs market
20122024
Net profit margin
58158500.0%
This company
8.1%
Market median
+718006073% vs market
20122024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122024
Debt / equity
163.43×
This company
0.62×
Market median
-26260% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MM Founder | Founder | 2013 | — | — |
TS Management | Management | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.3% | 33.3% | 2025 | |
RASMUS JAKOBSEN HOLDING RY ApS | Company | 33.3% | 33.3% | 2025 |
MICHAEL THYE HOLDING ApS | Company | 20.0% | 20.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MICHAEL THYE HOLDING ApS
MEDICOLINK CONSULTANCY ApS Board members of MEDICOLINK CONSULTANCY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Medicolink Magyarorszag | Founder | 0 companies |
| Tue Sand Larsen | Management | 0 companies |
| Rasmus Møller Jakobsen | Chairman | 0 companies |
| Michael Thye | Board of Directors | 0 companies |